Atlas FDA

Vanguard XP Knee System Porous Femoral Component various sizes and orientation a total knee replacement system. prosthes

FDA device recall Z-1265-2016 · posted 2016-03-25 · Terminated

Recall details

Recalling firm
Biomet, Inc.
Reason for recall
The anterior/posterior (AP) dimension may be oversized by 0.016. If the femoral component does not fit as tightly as intended, bony ingrowth may not occur causing loosening of the femoral component. A revision surgery may be necessary.
Action taken
On 2/5/2016, URGENT MEDICAL DEVICE RECALL NOTICE notifications were sent to the affected distributors, hospital risk managers, and implanting surgeons via courier. Distributors were instructed to locate and return the affected product, hospitals to locate and discontinue use, and implanting surgeons to monitor patients. The recall notification included a description of the reason for the recall, affected product, consignee responsibilities, and instructions for responding to the formal recall notification. Questions related to this notice should be directed to (574) 372-1570, Monday through Friday, 8 a.m. to 5 p.m.
Root cause
Device Design
Status
Terminated
Product code
MBH
Quantity affected
890
Distribution
UT Netherlands
Date initiated
2016-02-05
Date posted
2016-03-25
Date terminated
2017-03-28
Location
Warsaw, IN

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
VANGUARD XP FEMORAL COMPONENT(GEN II)/VANGUARD XP FEMORAL TRIAL (K141407)Biomet, Inc.2014-10-27